A critical advance in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant suppressor protein is frequently inactivated in several forms of https://classifylist.com/story23963072/mini-antibodies-revive-the-p53-protein-the-promising-approach-for-tumor-therapy